CNBC Television published this video item, entitled “Merck’s oral Covid-19 pill is a ‘profound game changer’: Gottlieb” – below is their description.
Dr. Scott Gottlieb, former FDA commissioner, joins CNBC’s “Squawk Box” to discuss Merck’s late-stage data for its oral Covid-19 pill molnupiravir.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
About This Source - CNBC Television
CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.
As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.
Please explain the following then, if we are to believe Molnupiravir is worthy of consideration for being a “safe and efficacious” COVID Therapeutic:
In April 2020, a whistleblower complaint by former Head of US Biomedical Advanced Research and Development Authority (BARDA) Rick Bright revealed concerns over providing funding for the further development of molnupiravir, due to similar drugs having mutagenic (DNA damaging) properties. A previous company, Pharmasset, that had investigated the drug’s active ingredient had abandoned it.